GlobalData’s flagship PharmaPoint report
series provides in-depth analysis of current dynamics and future evolution of global
These reports give you the key information you need to make strategic decisions.
Built up by therapy area experts, our reports allow you to get a full view of the
marketplace, including current industry trends, pipeline products, clinical trial
analysis, unmet need identification, therapy area corporate strategy and country
The superior value of PharmaPoint reports starts with a dive into disease management,
by country, to identify key specific drivers and barriers to treatment. Exhaustive
competitive landscape analysis and product profiling (SWOT analysis) contribute
to set the brand dynamics.
The bigger value of the series comes from insights delivered into the identification
of opportunities and unmet needs, in light of the assessment of company pipeline
and capability. This breadth of insights feeds into the market outlook, which is
underpinned by EpiCast epidemiology data. This, in turn, allows GlobalData to develop
a complex yet transparent drug, patient and country-level forecast model that covers
a period of ten years.
Why choose PharmaPoint?
Created with pharmaceutical decision-makers in mind, the reports incorporate all
the features we know to be vital to the formulation of successful business strategies.
Each report also leverages the depth of GlobalData’s proprietary database, and is
enriched with intelligence gathered through primary research with some of the industry’s
most highly informed key opinion leaders (KOLs) and high-prescribing non-KOL physicians.
This ensures that our market forecasts are based on fact and, above all, valuable
In addition to focusing on long-established markets such as the US, EU5 and Japan,
PharmaPoint reports also keep an eye on emerging and developing markets to assess
the promises and difficulties of such markets. Our Excel-based drug forecast models
support data presented in the reports, while the complete methodology is outlined
in both the report and the model. Our models provide you with disease prevalence
statistics, treatment rates, adoption rates, average selling prices, sales and more.
PharmaPoint reports allow you to make informed strategic decisions. Armed with the
qualitative insight from our reports and quantitative data from our market models,
you will be able to stay ahead of the competition and take advantage of new market
opportunities in the global marketplace.
Which business functions can PharmaPoint
- Competitive intelligence
- Market research
- Post launch brand management
- Lifecycle management
- Portfolio assessment